J. Messenger, S. Clark, S. Massick, and M. Bechtel, A review of trimethylaminuria: (fish odor syndrome), J Clin Aesthet Dermatol, vol.6, issue.11, pp.45-53, 2013.

M. Al-waiz, R. Ayesh, S. C. Mitchell, J. R. Idle, and R. L. Smith, Trimethylaminuria: the detection of carriers using a trimethylamine load test, J Inherit Metab Dis, vol.12, issue.1, pp.80-85, 1989.

M. Eugene, Diagnosis of "fish odor syndrome" by urine nuclear magnetic resonance proton spectrometry, Ann Dermatol Venereol, vol.125, issue.3, pp.210-212, 1998.

M. Eugène and . Trimethylaminurea, Orphanet Enc, vol.1, issue.3, 2002.

R. A. Chalmers, M. D. Bain, H. Michelakakis, J. Zschocke, and R. A. Iles, Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children, J Inherit Metab Dis, vol.29, issue.1, pp.162-72, 2006.

N. G. Abeling, A. H. Van-gennip, H. D. Bakker, A. Heerschap, U. Engelke et al., Diagnosis of a new case of trimethylaminuria using direct proton NMR spectroscopy of urine, J Inherit Metab Dis, vol.18, issue.2, pp.182-186, 1995.

K. A. Dacosta, J. J. Vrbanac, and S. H. Zeisel, The measurement of dimethylamine, trimethylamine, and trimethylamine N-oxide using capillary gas chromatography-mass spectrometry, Anal Biochem, vol.187, issue.2, pp.234-243, 1990.

D. W. Johnson, A flow injection electrospray ionization tandem mass spectrometric method for the simultaneous measurement of trimethylamine and trimethylamine N-oxide in urine, J Mass Spectrom, vol.43, issue.4, pp.495-504, 2008.

O. A. Mamer, L. Choiniere, and A. Lesimple, Measurement of urinary trimethylamine and trimethylamime oxide by direct infusion electrospray quadrupole timeof-flight mass spectrometry, Anal Biochem, vol.406, issue.1, pp.80-82, 2010.

W. Y. Hsu, W. Y. Lo, C. C. Lai, F. J. Tsai, C. H. Tsai et al., Rapid screening assay of trimethylaminuria in urine with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, Rapid Commun Mass Spectrom, vol.21, issue.12, pp.1915-1924, 2007.

S. Tjoa and P. Fennessey, The identification of trimethylamine excess in man: quantitative analysis and biochemical origins, Anal Biochem, vol.197, issue.1, pp.77-82, 1991.

S. Maschke, A. Wahl, N. Azaroual, O. Boulet, V. Crunelle et al., 1H-NMR analysis of trimethylamine in urine for the diagnosis of fish-odour syndrome, Clin Chim Acta, vol.263, issue.2, pp.139-185, 1997.

C. T. Dolphin, A. Janmohamed, R. L. Smith, E. A. Shephard, and I. R. Phillips, Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome, Nat Genet, vol.17, issue.4, pp.491-495, 1997.

E. P. Treacy, B. R. Akerman, L. M. Chow, R. Youil, C. Bibeau et al., Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication, Hum Mol Genet, vol.7, issue.5, pp.839-884, 1998.

J. Zschocke, D. Kohlmueller, E. Quak, T. Meissner, G. F. Hoffmann et al., Mild trimethylaminuria caused by common variants in FMO3 gene, Lancet, vol.354, issue.9181, pp.834-839, 1999.

H. Yamazaki, H. Fujita, T. Gunji, J. Zhang, T. Kamataki et al., Stop codon mutations in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population, Mol Genet Metab, vol.90, issue.1, pp.58-63, 2007.

H. Yamazaki and M. Shimizu, Genetic polymorphism of the flavin-containing monooxygenase 3 (FMO3) associated with trimethylaminuria (fish odor syndrome): observations from Japanese patients, Curr Drug Metab, vol.8, issue.5, pp.487-91, 2007.

M. Shimizu, Y. Kobayashi, S. Hayashi, Y. Aoki, and H. Yamazaki, Variants in the flavincontaining monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population, Mol Genet Metab, vol.107, issue.3, pp.330-334, 2012.

J. R. Cashman, Y. A. Bi, J. Lin, R. Youil, M. Knight et al., Human flavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria, Chem Res Toxicol, vol.10, issue.8, pp.837-878, 1997.

C. S. Park, J. H. Kang, W. G. Chung, H. G. Yi, J. E. Pie et al., Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms: linkage and effects on in vivo and in vitro FMO activities, Pharmacogenetics, vol.12, issue.1, pp.77-80, 2002.

V. Lattard, J. Zhang, Q. Tran, B. Furnes, D. Schlenk et al., Two new polymorphisms of the FMO3 gene in Caucasian and African-American populations: comparative genetic and functional studies, Drug Metab Dispos, vol.31, issue.7, pp.854-60, 2003.

M. Al-waiz, R. Ayesh, S. C. Mitchell, J. R. Idle, and R. L. Smith, A genetic polymorphism of the N-oxidation of trimethylamine in humans, Clin Pharmacol Ther, vol.42, issue.5, pp.588-94, 1987.

Y. Guo, L. D. Hwang, J. Li, J. Eades, C. W. Yu et al., Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing, BMC Med Genet, vol.18, issue.1, p.11, 2017.

M. Shimizu, H. Yano, S. Nagashima, N. Murayama, J. Zhang et al., Effect of genetic variants of the human flavin-containing monooxygenase 3 on N-and S-oxygenation activities, Drug Metab Dispos, vol.35, issue.3, pp.328-358, 2007.

D. M. Lambert, O. A. Mamer, B. R. Akerman, L. Choiniere, D. Gaudet et al., In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene, Mol Genet Metab, vol.73, issue.3, pp.224-233, 2001.

A. Brunelle, Y. A. Bi, J. Lin, B. Russell, L. Luy et al., Characterization of two human flavin-containing monooxygenase (form 3) enzymes expressed in Escherichia coli as maltose binding protein fusions, Drug Metab Dispos, vol.25, issue.8, pp.1001-1008, 1997.

A. Q. Zhang, S. C. Mitchell, and R. L. Smith, Exacerbation of symptoms of fish-odour syndrome during menstruation, Lancet, vol.348, issue.9043, pp.1740-1741, 1996.

S. C. Mitchell and R. L. Smith, Trimethylaminuria: the fish malodor syndrome, Drug Metab Dispos, vol.29, issue.4, pp.517-538, 2001.

N. J. Manning, E. K. Allen, R. J. Kirk, M. J. Sharrard, and E. J. Smith, Riboflavin-responsive trimethylaminuria in a patient with homocystinuria on betaine therapy, JIMD Rep, vol.5, pp.71-76, 2012.

F. Rocher, C. Caruba, F. Broly, and C. Lebrun, L-carnitine treatment and fish odor syndrome: an unwaited adverse effect, Rev Neurol (Paris), vol.167, issue.6-7, pp.541-545, 2011.

P. Podadera, A. M. Sipahi, J. A. Areas, and U. M. Lanfer-marquez, Diagnosis of suspected trimethylaminuria by NMR spectroscopy, Clin Chim Acta, vol.351, issue.1-2, pp.149-54, 2005.

M. Begum and P. J. Mckenna, Olfactory reference syndrome: a systematic review of the world literature, Psychol Med, vol.41, issue.3, pp.453-61, 2011.

D. J. Stein, L. Roux, L. Bouwer, C. Van-heerden, and B. , Is olfactory reference syndrome an obsessive-compulsive spectrum disorder?: two cases and a discussion, J Neuropsychiatry Clin Neurosci, vol.10, issue.1, pp.96-105, 1998.

J. D. Feusner, K. A. Phillips, and D. J. Stein, Olfactory reference syndrome: issues for DSM-V, Depress Anxiety, vol.27, issue.6, pp.592-601, 2010.

J. L. Greenberg, A. M. Shaw, L. Reuman, R. Schwartz, and S. Wilhelm, Clinical features of olfactory reference syndrome: an internet-based study, J Psychosom Res, vol.80, pp.11-17, 2016.

P. M. Wise, J. Eades, S. Tjoa, P. V. Fennessey, and G. Preti, Individuals reporting idiopathic malodor production: demographics and incidence of trimethylaminuria, Am J Med, vol.124, issue.11, pp.1058-63, 2011.

K. Suzuki, N. Takei, Y. Iwata, Y. Sekine, T. Toyoda et al., Do olfactory reference syndrome and jiko-shu-kyofu (a subtype of taijin-kyofu) share a common entity?, Acta Psychiatr Scand, vol.109, issue.2, pp.150-155, 2004.

K. A. Phillips and W. Menard, Olfactory reference syndrome: demographic and clinical features of imagined body odor, Gen Hosp Psychiatry, vol.33, issue.4, pp.398-406, 2011.

Y. Takekita, M. Kato, S. Sakai, A. Suwa, K. Nishida et al., Olfactory reference syndrome treated by blonanserin augmentation, Psychiatry Clin Neurosci, vol.65, issue.2, pp.203-207, 2011.

R. K. Olsen, S. E. Olpin, B. S. Andresen, Z. H. Miedzybrodzka, M. Pourfarzam et al., ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency, Brain, vol.130, pp.2045-54, 2007.

S. H. Moolenaar, J. Poggi-bach, U. F. Engelke, J. M. Corstiaensen, A. Heerschap et al., Defect in dimethylglycine dehydrogenase, a new inborn error of metabolism: NMR spectroscopy study, Clin Chem, vol.45, issue.4, pp.459-64, 1999.

H. Yamazaki and M. Shimizu, Survey of variants of human flavin-containing monooxygenase 3 (FMO3) and their drug oxidation activities, Biochem Pharmacol, vol.85, issue.11, pp.1588-93, 2013.

R. D'angelo, C. Scimone, T. Esposito, D. Bruschetta, C. Rinaldi et al., Fish odor syndrome (trimethylaminuria) supporting the possible FMO3 down expression in childhood: a case report, J Med Case Rep, vol.8, p.328, 2014.

C. K. Yeung, E. T. Adman, and A. E. Rettie, Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria, Arch Biochem Biophys, vol.464, issue.2, pp.251-260, 2007.

C. T. Dolphin, A. Janmohamed, R. L. Smith, E. A. Shephard, and I. R. Phillips, Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FM03) gene in patients with fish-odour syndrome, Pharmacogenetics, vol.10, issue.9, pp.799-807, 2000.

B. Furnes, J. Feng, S. S. Sommer, and D. Schlenk, Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans, Drug Metab Dispos, vol.31, issue.2, pp.187-93, 2003.

J. R. Cashman, K. Camp, S. S. Fakharzadeh, P. V. Fennessey, R. N. Hines et al., Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria, Curr Drug Metab, vol.4, issue.2, pp.151-70, 2003.

I. R. Phillips and E. A. Shephard, Flavin-containing monooxygenases: mutations, disease and drug response, Trends Pharmacol Sci, vol.29, issue.6, pp.294-301, 2008.

C. Zuppi, I. Messana, F. Forni, C. Rossi, L. Pennacchietti et al., 1H NMR spectra of normal urines: reference ranges of the major metabolites, Clin Chim Acta, vol.265, issue.1, pp.85-97, 1997.

, Publisher's Note

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations